However, DOK5 expression was significantly increased in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), and stomach adenocarcinoma (STAD), compared to adjacent normal tissues. This evidence concerns the gene DOK5 and cholangiocarcinoma.